Your browser doesn't support javascript.
loading
Efficacy and safety of baricitinib in Japanese patients with autoinflammatory type I interferonopathies (NNS/CANDLE, SAVI, And AGS).
Kanazawa, Nobuo; Ishii, Taeko; Takita, Yasushi; Nishikawa, Atsushi; Nishikomori, Ryuta.
Affiliation
  • Kanazawa N; Department of Dermatology, Hyogo Medical University, Nishinomiya, Japan.
  • Ishii T; Eli Lilly Japan K.K, Lilly Plaza One Bldg., 5-1-28, Isogamidori, Chuo-ku, Kobe, 651-0086, Japan. ishii_taeko@lilly.com.
  • Takita Y; Eli Lilly Japan K.K, Lilly Plaza One Bldg., 5-1-28, Isogamidori, Chuo-ku, Kobe, 651-0086, Japan.
  • Nishikawa A; Eli Lilly Japan K.K, Lilly Plaza One Bldg., 5-1-28, Isogamidori, Chuo-ku, Kobe, 651-0086, Japan.
  • Nishikomori R; Department of Pediatrics and Child Health, Kurume University School of Medicine, Kurume, Japan.
Pediatr Rheumatol Online J ; 21(1): 38, 2023 Apr 22.
Article in En | MEDLINE | ID: mdl-37087470

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interferon Type I / Hereditary Autoinflammatory Diseases / Janus Kinase Inhibitors / East Asian People Type of study: Clinical_trials Limits: Adult / Child / Female / Humans / Male Language: En Journal: Pediatr Rheumatol Online J Year: 2023 Document type: Article Affiliation country: Japan Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interferon Type I / Hereditary Autoinflammatory Diseases / Janus Kinase Inhibitors / East Asian People Type of study: Clinical_trials Limits: Adult / Child / Female / Humans / Male Language: En Journal: Pediatr Rheumatol Online J Year: 2023 Document type: Article Affiliation country: Japan Country of publication: United kingdom